<DOC>
	<DOCNO>NCT00240214</DOCNO>
	<brief_summary>The purpose study obtain data effectiveness safety Rapamune everyday condition</brief_summary>
	<brief_title>Study Evaluating Rapamune Patients After Kidney Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients receive renal allograft cadaveric live donor low moderate risk develop acute rejection episode . Contraindications accord Summary Product Characteristics ( SmPC ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Kidney transplant</keyword>
</DOC>